What's New - 23/07/2024
Content Updates| Platform Tips| Trending Articles
Academy Highlights
Elevate your professional skills with our latest courses in the Academy:
- Basic Airborne Infection Prevention and Control
- Clinical Management of Cardio and Common Vascular Disease
- Infection Control in Healthcare Facilities
- Pharmacy Practice Management: Statutory requirements, ethics and law for pharmacists
- Preceptorship Model for Professional Nurses
New Content Added
Active Ingredient Monograph(s)
Analgesia: Diclofenac (MOW/SPO)
Continued Professional Development (CPDs):
Webinar invite: 25 July 2024: The Impact of NHI on healthcare service providers and users
Health Awareness Focus
July is Mental Illness Awareness month and we have specially selected articles that touch on various topics relevant to this mental health. Check these out below:
- Bipolar disorder: assessment and management
- Clinical insights for major depressive disorder
- Management of schizophrenia: clinical insights and best practice
Spotlight on Groundbreaking Research
Discover the Latest in HIV Prevention
In this edition, we highlight the remarkable findings from a recent Phase 3 clinical trial on lenacapavir. This long-acting injectable medication has shown significant promise in preventing HIV among adolescent girls and young women, a group particularly vulnerable to the virus.
Learn about the study's key results, the potential impact on HIV prevention strategies, and what this means for the future of HIV care. Click here to find out more.
Content Updated
Active Ingredient Monograph(s)
- Genitourinary: Solifenacin (TAB/FCT)
- Pulmonary: Caffeine Citrate (INJ)
EMGuidance Script - Free 14-day trial!
EMGuidance Script now offers a 14-day free trial for registered doctors!
If you are interested in experiencing EMGuidance Script before you subscribe, please click on "Script" when logged into EMGuidance on a web browser, or download the EMGuidance Script app today.
For any queries please contact our support team at script@emguidance.com.
Trending Articles
- Bisoprolol: A Key Player in Hypertension & Heart Failure
- Glucophage® XR - a unique release mechanism
- WHO updates laboratory biosecurity guidance
- Haloperidol (oral) versus olanzapine (oral) for people with schizophrenia and schizophrenia‐spectrum disorders